BPTSY (Biophytis) Cash Flow from Others: $-0.95 Mil (TTM As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BPTSY Biophytis SA BPTSY
19 GF Score
Price $0.25
! 4 Warning Signs
View Full Analysis

What is Biophytis Cash Flow from Others?

Biophytis BPTSY 19 Cash Flow from Others is $-0.95 Mil as of Jun. 2025. GuruFocus rates BPTSY with a GF Score™ of 19/100. The stock has 4 warning signs investors should review.

Biophytis's cash flow from others for the six months ended in Jun. 2025 was $-0.74 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Jun. 2025 was $-0.95 Mil.

Biophytis Cash Flow from Others Related Terms

Biophytis Cash Flow from Others Historical Data

* Premium members only.

The historical data trend for Biophytis's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biophytis Cash Flow from Others Chart

Biophytis Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Others
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.98 2.97 0.54 2.80 1.35

Biophytis Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.15 1.64 1.60 -0.20 -0.74
BPTSY
19GF Score
Biophytis SA BPTSY
Cash Flow from Others is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biophytis Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.95 Mil.

Frequently Asked Questions Learn more about Cash Flow from Others →
What does a Cash Flow from Others of $-0.95 Mil mean?
Biophytis (BPTSY) has a Cash Flow from Others of $-0.95 Mil as of Jun. 2025. Cash Flow from Others is the amount of cash earned or paid from other, nonstandard operations. View historical data for Biophytis and its competitors.
Is Biophytis' Cash Flow from Others too high?
Biophytis' current Cash Flow from Others is $-0.95 Mil. Overall, Biophytis has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Biophytis' Cash Flow from Others compare to VRTX and REGN?
Biophytis' Cash Flow from Others of $-0.95 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Others for a Biotechnology company?
A good Cash Flow from Others depends on the Biotechnology industry context. However, Cash Flow from Others should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Others mean?
A high Cash Flow from Others can signal that a stock is expensive relative to its fundamentals. Cash Flow from Others is the amount of cash earned or paid from other, nonstandard operations. View historical data for Biophytis and its competitors. Biophytis's current Cash Flow from Others is $-0.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biophytis stock overvalued right now?
Biophytis (BPTSY) has a current Cash Flow from Others of $-0.95 Mil. The current Cash Flow from Others is $-0.95 Mil. Biophytis' overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Others calculated?
Cash Flow from Others is calculated from a company's financial statements. For Biophytis (BPTSY), the current Cash Flow from Others is $-0.95 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biophytis Business Description

Address BC 9, Batiment A 4eme etage, 4 Place Jussieu, Sorbonne University, Paris, FRA, 75005
Biophytis SA is a France-based clinical-stage biotechnology company engaged in the development of drug candidates for the treatment of age-related and respiratory diseases. The company focuses on therapies that target degenerative processes associated with aging and improve functional outcomes. Its drug candidate, BIO101, is an orally administered small molecule under development for neuromuscular and respiratory indications, including sarcopenia, Duchenne muscular dystrophy (DMD), and respiratory failure.
19GF Score

Get the complete analysis for BPTSY

Cash Flow from Others is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.25
Price